» Articles » PMID: 31420016

Genetic Variation in Interleukin-7 is Associated with a Reduced Erythropoietic Response in Kenyan Children Infected with Plasmodium Falciparum

Overview
Journal BMC Med Genet
Publisher Biomed Central
Specialty Genetics
Date 2019 Aug 18
PMID 31420016
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Severe malarial anemia (SMA) is a leading cause of malaria-related morbidity and mortality in children. The genetic factors that influence development of SMA and inefficient erythropoiesis, a central pathogenic feature of SMA, are only partially understood.

Methods: We performed a pilot Genome-wide Association Study (GWAS) on children with Plasmodium falciparum. The GWAS was performed using the Illumina® Infinium® HD Super Assay in conjunction with Illumina's® Human Omni2.5-8v1 BeadChip (with > 2.45 M markers). Data were analyzed using single SNP logistic regression analysis with an additive model of inheritance controlling for covariates. Results from our pilot global genomics study identified that variation in interleukin (IL)-7 was associated with enhanced risk of SMA. To validate this finding, we investigated the relationship between genotypes and/or haplotypes of two single nucleotide polymorphisms (SNPs) in IL7 [72194 T/C and - 2440 A/G] and susceptibility to both SMA and inefficient erythropoiesis [i.e., reticulocyte production index (RPI) < 2.0 in anemic children (Hb < 11.0 g/dL). Children presenting with P. falciparum malaria (< 3 years, n = 883) were stratified into two groups: Uncomplicated malaria (UM, n = 718) and SMA (n = 165).

Results: Regression modeling, controlling for anemia-related confounders, revealed that carriage of the TC genotype at position 72194 T/C was associated with enhanced susceptibility to inefficient erythropoiesis (OR = 1.90; 95% CI 1.09-3.30; P = 0.02) as was homozygous CC (OR 5.14; 95% CI = 1.20-21.99; P = 0.03). Consistent with this finding, individuals with the CA (72194C/-2440A) haplotype had an increased risk of inefficient erythropoiesis (OR = 1.90; 95% CI = 1.10-3.30; P = 0.02), whereas TA haplotype carriers had marginal protection against inefficient erythropoiesis (OR = 0.24; 95% CI = 0.06-1.21; P = 0.05). These observations were supported by Cochran-Armitage trend test for inefficient erythropoiesis (CA > TA > CG; P < 0.01). Although none of the genotype and/or haplotypic variants were significantly associated with SMA, the direction of the risk profiles were consistent with the erythropoiesis results.

Conclusion: Taken together, variation in IL7 is associated with erythropoietic responses in children with falciparum malaria, a central physiological feature contributing to development of SMA.

Citing Articles

Plasma Soluble Progenitor Cell Receptors as Biomarkers for Severe Anemia Among Malaria-Infected Pediatrics: A Prospective Study in Ghana.

Nkansah C, Appiah S, Osei-Boakye F, Appiah-Kubi E, Abbam G, Daud S Health Sci Rep. 2025; 8(2):e70460.

PMID: 39931259 PMC: 11808392. DOI: 10.1002/hsr2.70460.


Transcriptomic and Proteomic Insights into Host Immune Responses in Pediatric Severe Malarial Anemia: Dysregulation in HSP60-70-TLR2/4 Signaling and Altered Glutamine Metabolism.

Onyango C, Anyona S, Hurwitz I, Raballah E, Wasena S, Osata S Pathogens. 2024; 13(10).

PMID: 39452740 PMC: 11510049. DOI: 10.3390/pathogens13100867.


Pro- and anti-inflammatory cytokines mediate the progression of severe anemia in malaria-infected children: A prospective study.

Nkansah C, Osei-Boakye F, Abbam G, Appiah S, Daud S, Boakye B Immun Inflamm Dis. 2024; 12(9):e70013.

PMID: 39240033 PMC: 11378270. DOI: 10.1002/iid3.70013.


Human NCR3 gene variants rs2736191 and rs11575837 alter longitudinal risk for development of pediatric malaria episodes and severe malarial anemia.

Onyango C, Cheng Q, Munde E, Raballah E, Anyona S, McMahon B BMC Genomics. 2023; 24(1):542.

PMID: 37704951 PMC: 10498606. DOI: 10.1186/s12864-023-09565-1.


Integrated Analysis of Cytokine Profiles in Malaria Patients Discloses Selective Upregulation of TGF-β1, β3, and IL-9 in Mild Clinical Presentation.

Ndoricyimpaye E, Van Snick J, Niyoyita J, Kanimba P, Mbonimpa J, Rutayisire R Int J Mol Sci. 2022; 23(20).

PMID: 36293524 PMC: 9603849. DOI: 10.3390/ijms232012665.


References
1.
Novelli E, Hittner J, Davenport G, Ouma C, Were T, Obaro S . Clinical predictors of severe malarial anaemia in a holoendemic Plasmodium falciparum transmission area. Br J Haematol. 2010; 149(5):711-21. PMC: 3095459. DOI: 10.1111/j.1365-2141.2010.08147.x. View

2.
Aiello F, Keller J, Klarmann K, Dranoff G, Mazzucchelli R, Durum S . IL-7 induces myelopoiesis and erythropoiesis. J Immunol. 2007; 178(3):1553-63. DOI: 10.4049/jimmunol.178.3.1553. View

3.
Price R, Simpson J, Nosten F, Luxemburger C, Hkirjaroen L, Ter Kuile F . Factors contributing to anemia after uncomplicated falciparum malaria. Am J Trop Med Hyg. 2001; 65(5):614-22. PMC: 4337986. DOI: 10.4269/ajtmh.2001.65.614. View

4.
Phillips R, Looareesuwan S, Warrell D, Lee S, Karbwang J, Warrell M . The importance of anaemia in cerebral and uncomplicated falciparum malaria: role of complications, dyserythropoiesis and iron sequestration. Q J Med. 1986; 58(227):305-23. View

5.
Zuvich R, McCauley J, Oksenberg J, Sawcer S, De Jager P, Aubin C . Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility. Hum Genet. 2010; 127(5):525-35. PMC: 2854871. DOI: 10.1007/s00439-010-0789-4. View